Prostate cancer in men 70 years old or older, indolent or aggressive: Clinicopathological analysis and outcomes

Journal of Urology

Volumn 185, Issue 1, 2011, Pages 132-137

  Brassell, Stephen A ^a,b   Rice, Kevin R ^a   Parker, Patrick M ^a   Chen, Yongmei ^b   Farrell, James S ^a   Cullen, Jennifer ^b   McLeod, David G ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b Center for Prostate Disease Research   (United States)

Author keywords

Age factors; Early detection of cancer; Prostate specific antigen; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CRYOTHERAPY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE;

AGED; HUMANS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 78650029086     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.09.014     Document Type: Article

References (17)

1. U.S. Preventive Services Task Force Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 149 2008 185
2. American Cancer Society Screening Guidelines http://www.cancer.org 2009
3. K.L. Greene, P.C. Albertsen, and R.J. Babaian Prostate specific antigen best practice statement: 2009 update J Urol 182 2009 2232
4. P.C. Albertsen, D.G. Fryback, and B.E. Storer Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626
5. P.C. Albertsen, D.G. Fryback, and B.E. Storer The impact of co-morbidity on life expectancy among men with localized prostate cancer J Urol 156 1996 127
6. R.W. Barnes Survival with conservative therapy JAMA 210 1969 331
7. B. Furusato, C.L. Gao, and L. Ravindranath Mapping of TMPRSS2-ERG fusions in the context of multi-focal prostate cancer Mod Pathol 21 2008 67
8. A.V. D'Amico, K. Cote, and M. Loffredo Advanced age at diagnosis is an independent predictor of time to death from prostate carcinoma for patients undergoing external beam radiation therapy for clinically localized prostate carcinoma Cancer 97 2003 56
9. K.L. Schwartz, S.M. Alibhai, and G. Tomlinson Continued undertreatment of older men with localized prostate cancer Urology 62 2003 860
10. K.S. Ross, and H.A. Guess Estimation of treatment benefits when PSA screening for prostate cancer is discontinued at different ages Urology 66 2005 1038
11. J.C. Massengill, L. Sun, and J.W. Moul Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy J Urol 169 2003 1670
12. C.A. Heinlein, and C. Chang Androgen receptor in prostate cancer Endocr Rev 25 2004 276
13. E. Rickter, S. Srivastava, and A. Dobi Androgen receptor and prostate cancer Prostate Cancer Prostatic Dis 10 2007 114
14. B.K. Isariyawongse, L. Sun, and L.L. Baez Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen Urology 72 2008 882
15. B. Kessler, and P. Albertsen The natural history of prostate cancer Urol Clin North Am 30 2003 219
16. National Center for Health Statistics: Health, United States, 2004 U.S. Department of Health and Human Services Hyattsville, Maryland 2004
17. E. Arias United States life tables, 2003 Natl Vital Stat Rep 54 2006 1